Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Rad Chat, Naman Julka-Anderson, and Jo McNamara. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Rad Chat, Naman Julka-Anderson, and Jo McNamara or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Rad Chat Live at UKIO Conference 2025 #24: Maryam Akhtarini - Hypoxia Challenge

8:45
 
Share
 

Manage episode 486649247 series 3011641
Content provided by Rad Chat, Naman Julka-Anderson, and Jo McNamara. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Rad Chat, Naman Julka-Anderson, and Jo McNamara or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Trigger Warning: cancer treatment, cancer and side effects.

Bonus Episode: Rad Chat Live at UKIO Conference 2025 with Maryam Akhtarini.

Stay ahead in radiotherapy and oncology by liking, following, and subscribing to Rad Chat wherever you get your podcasts.

Join our supportive community of professionals who truly get it. Follow us @Rad__Chat and visit our website at www.radchat.co.uk. Together, we’re pushing boundaries in cancer care.

Maryam’s links:
FDA Approval of Histotripsy for Liver Tumors (Oct 2023)
https://www.fda.gov/news-events/press-announcements/fda-roundup-october-13-2023
https://www.fusfoundation.org/posts/fda-approves-histotripsy-for-liver-tumors/

UK Early Market Access via IDAP (May 2025)
https://www.businesswire.com/news/home/20250529975697/en/HistoSonics-Edison-Histotripsy-System-Gains-Great-Britain-Early-Market-Access-Under-Unmet-Clinical-Needs-Authorisation

HOPE4LIVER Trial Results (April 2025)
https://www.businesswire.com/news/home/20250428931117/en/HistoSonics-Histotripsy-System-Demonstrates-90-Local-Tumor-Control-at-12-Months-in-HOPE4LIVER-Trials
https://www.fusfoundation.org/posts/histotripsy-for-liver-tumors-one-year-data-suggest-90-tumor-control/

Histotripsy Overview (Non-Thermal Ultrasound)
https://ammf.org.uk/2025/05/30/histotripsy-and-cholangiocarcinoma/

NanOx and Tumour Hypoxia – Cancer Letters (Dec 2024)
https://pubmed.ncbi.nlm.nih.gov/39716484/https://www.researchgate.net/publication/387307211_Enhancing_cancer_radiotherapy_efficacy_using_NanOx_a_novel_oxygenating_perfluorocarbon_nanoemulsion_that_reverses_tumour_hypoxia
https://www.sciencedirect.com/science/article/abs/pii/S0304383524008012

Rad Chat Links:

  continue reading

398 episodes

Artwork
iconShare
 
Manage episode 486649247 series 3011641
Content provided by Rad Chat, Naman Julka-Anderson, and Jo McNamara. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Rad Chat, Naman Julka-Anderson, and Jo McNamara or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Trigger Warning: cancer treatment, cancer and side effects.

Bonus Episode: Rad Chat Live at UKIO Conference 2025 with Maryam Akhtarini.

Stay ahead in radiotherapy and oncology by liking, following, and subscribing to Rad Chat wherever you get your podcasts.

Join our supportive community of professionals who truly get it. Follow us @Rad__Chat and visit our website at www.radchat.co.uk. Together, we’re pushing boundaries in cancer care.

Maryam’s links:
FDA Approval of Histotripsy for Liver Tumors (Oct 2023)
https://www.fda.gov/news-events/press-announcements/fda-roundup-october-13-2023
https://www.fusfoundation.org/posts/fda-approves-histotripsy-for-liver-tumors/

UK Early Market Access via IDAP (May 2025)
https://www.businesswire.com/news/home/20250529975697/en/HistoSonics-Edison-Histotripsy-System-Gains-Great-Britain-Early-Market-Access-Under-Unmet-Clinical-Needs-Authorisation

HOPE4LIVER Trial Results (April 2025)
https://www.businesswire.com/news/home/20250428931117/en/HistoSonics-Histotripsy-System-Demonstrates-90-Local-Tumor-Control-at-12-Months-in-HOPE4LIVER-Trials
https://www.fusfoundation.org/posts/histotripsy-for-liver-tumors-one-year-data-suggest-90-tumor-control/

Histotripsy Overview (Non-Thermal Ultrasound)
https://ammf.org.uk/2025/05/30/histotripsy-and-cholangiocarcinoma/

NanOx and Tumour Hypoxia – Cancer Letters (Dec 2024)
https://pubmed.ncbi.nlm.nih.gov/39716484/https://www.researchgate.net/publication/387307211_Enhancing_cancer_radiotherapy_efficacy_using_NanOx_a_novel_oxygenating_perfluorocarbon_nanoemulsion_that_reverses_tumour_hypoxia
https://www.sciencedirect.com/science/article/abs/pii/S0304383524008012

Rad Chat Links:

  continue reading

398 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play